Health-related quality of life (HRQoL) and symptom burden in patients (Pts) with myelofibrosis (MF) in the COMFORT-II study.
Jean-Jacques Kiladjian
Research Funding - Celgene; Novartis; Shire (B)
Heinz Gisslinger
No relevant relationships to disclose
Francesco Passamonti
Consultant or Advisory Role - Celgene; Novartis; Sanofi
Dietger Niederwieser
Consultant or Advisory Role - Novartis
Estella Mendelson
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
L. Andres Sirulnik
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Kati Copley-Merriman
Employment or Leadership Position - Incyte
Xiaolei Zhou
Employment or Leadership Position - Incyte
Richard S. Levy
Employment or Leadership Position - Incyte
Stock Ownership - Incyte
Laurent Knoops
Consultant or Advisory Role - Novartis
Expert Testimony - Novartis
Francisco Cervantes
Consultant or Advisory Role - Novartis
Tiziano Barbui
No relevant relationships to disclose
Giovanni Barosi
No relevant relationships to disclose
Alessandro M. Vannucchi
Consultant or Advisory Role - Italfarmaco; Novartis
Honoraria - Italfarmaco; Novartis
Claire N Harrison
Consultant or Advisory Role - Celgene; Celgene; Novartis; Novartis; Sa bio; Sanofi ; Sanofi ; SBio; YM BioSciences; YM BioSciences
Honoraria - Celgene; Celgene; Novartis; Novartis; S Bio; Sanofi ; Sanofi ; SBio; YM BioSciences; YM BioSciences
Research Funding - Novartis; Novartis
Expert Testimony - S Bio; SBio